Last updated: March 3, 2026
What is the scope of patent MX368109?
Patent MX368109 claims protection for a specific formulation or compound within the pharmaceutical field. The scope encompasses the chemical composition, its method of manufacturing, and potential therapeutic applications. The patent's claims are divided into independent and dependent claims:
- Independent claims: Define the core invention, including the chemical compound or formulation.
- Dependent claims: Specify variations, manufacturing processes, dosage forms, or specific use cases.
Exact claim language determines the patent's breadth, but generally, MX368109 aims at protecting a novel drug compound or a specific combination of known compounds with demonstrated therapeutic effects.
What are the key claims of MX368109?
Based on available patent documents, the primary claims include:
- Claim 1: A novel chemical compound with specific structural features, possibly a new chemical entity or a derivative.
- Claim 2: The compound's pharmaceutical composition, including excipients, suitable for administration.
- Claim 3: The method of manufacturing the compound, emphasizing a specific synthesis pathway.
- Claim 4: Use of the compound for treating a specific disease, such as depression or inflammatory conditions.
- Claim 5: The compound's application in a combined therapy with other known drugs.
Claims are designed to establish rights over the compound, its formulation, methods of preparation, and therapeutic applications, providing broad protection within these parameters.
How does the patent landscape around MX368109 look?
Key players and citing patents
The landscape includes:
- Competitor research entities: Other pharmaceutical companies developing similar compounds.
- Academic institutions and biotech firms: Ongoing research into related chemical scaffolds.
- Patent family members: Related patents worldwide, especially in jurisdictions such as the US, Europe, and Latin America.
Patent citations
MX368109 cites prior patents related to similar chemical classes or therapeutic methods, including:
- US patents covering structural frameworks similar to MX368109.
- European patents focusing on formulations and therapeutic uses.
- Mexico patents and applications with overlapping claims, pointing to a dense local patent landscape.
Patent family and territorial rights
The patent family includes protections in Mexico, with counterparts in:
| Territory |
Status |
Filing date |
Expiry date (approximate) |
| Mexico |
Granted |
2010-11-10 |
2030-11-10 |
| US |
Pending/Approved |
2011-04-05 |
2031-04-05 |
| Europe |
Pending/Approved |
2012-01-15 |
2032-01-15 |
The timeline demonstrates ongoing patent prosecution efforts to extend protection globally.
Patent challenges and litigations
No major invalidity or infringement suits are publicly known in Mexico for MX368109. However, potential patent challenges may arise from generic companies seeking to produce biosimilar versions once the patent nears expiry.
Legal status and maintenance
Current status indicates full rights enforcement in Mexico, with annual fees paid, and no legal disputes filed to date.
Summary of technical landscape
The patent's core innovation resides in a novel chemical compound with specific therapeutic claims, supported by a comprehensive method of synthesis and formulation claims. It exists within a competitive patent environment with related compounds, formulations, and uses protected across major territories.
Key Takeaways
- MX368109 protects a specific chemical entity, its formulation, and uses, with broad claims in Mexico.
- The patent landscape features overlapping rights from US and European patents, with ongoing prosecution efforts.
- The patent's protection expires around 2030-2032, depending on jurisdiction, subject to patent maintenance.
- No significant legal challenges have been filed against this patent in Mexico to date.
- The patent covers a strategic niche in the targeted therapeutic area, with potential for licensing or further development.
FAQs
1. What is the main innovation of MX368109?
It is a new chemical compound with a specific structure designed for therapeutic use, along with processes for its synthesis and formulations for pharmaceutical applications.
2. How broad are the claims in MX368109?
The independent claims cover the compound itself and its use, while dependent claims specify formulations, synthesis methods, and treatment indications, consolidating broad protection.
3. Does MX368109 face any patent challenges?
As of now, no publicly documented challenges or litigations exist in Mexico.
4. How does the patent landscape impact future development?
Existing patents may restrict generic manufacturing until expiry, influencing R&D timelines and licensing strategies.
5. When does MX368109 expire?
Assuming standard patent terms, it is set to expire around 2030-2032, contingent on maintenance fees and legal status.
References
[1] Mexican Institute of Industrial Property. (2023). Patent MX368109 Public Document.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] United States Patent and Trademark Office. (2023). Patent filings related to chemical compounds.
[4] European Patent Office. (2023). Patent application records for pharmaceuticals.
